11.12.2025 • Topics

Resilience, Adaptability, and Efficiency

Executives of Azelis, Biesterfeld, Brenntag, IMCD, and Nordmann share their opinions

Photo
© Benjamin – stock.adobe.com

The chemical distribution outlook report by Boston Consulting Group, outlined on the previous pages, presents six key findings that capture the strategic pressures and capability shifts transforming the chemical disgtribution landscape, setting the stage for four imperatives that will help distributors to win amid uncertainty. Madjar Navah, one of the authors of the report, introduced the most significant results of the study at the FECC Annual Meeting in Hamburg, Germany, in mid-September. Among the audience were executives of the largest chemical distribution companies, some of which we asked to share their opinions on the report’s conclusions with us. It is obvious that the leaders of Azelis, Biesterfeld, Brenntag, IMCD, and Nordmann share a clear common ground: all five emphasize the need for resilience, adaptability, and efficiency in the face of industry uncertainty and transformation. They highlight the importance of building robust and flexible supply chains, investing in digital and technological capabilities, and most notably, prioritizing their people. They also stress the balance between operational efficiency and forward-looking investments, particularly in digitalization and sustainability. Ultimately, the leaders agree that the future of chemical distribution will be shaped by those who combine technological advancement with human expertise, collaboration, and strong customer focus.

Continue with login

No account yet?

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Register

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read